Results 301 to 310 of about 658,933 (385)
Remote patient monitoring in heart failure (HF). Abstract AimsMethods of non‐invasive remote patient monitoring (RPM) for heart failure (HF) remain diverse. Understanding factors that influence the effectiveness of RPM on HF‐related and all‐cause hospitalizations, mortality, and emergency department visits is crucial for developing successful RPM ...
Ignace L.J. De Lathauwer+6 more
wiley +1 more source
Medical Equipment Planning in Ambulatory Surgery Centers: Enhancing Efficiency, Innovation, and Patient Care. [PDF]
Nandy B, Jha M.
europepmc +1 more source
Clinical applications of urinary sodium in heart failure from prognostic marker to clinical tool
ESC Heart Failure, EarlyView.
Dauw Jeroen
wiley +1 more source
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. ARNI, angiotensin receptor/neprilysin inhibitor; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate; GDMT, guideline‐directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection ...
Clara I. Saldarriaga+21 more
wiley +1 more source
Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies. [PDF]
Nambu Y+8 more
europepmc +1 more source
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, rate ratio. Abstract Aims The efficacy and safety of the non‐steroidal mineralocorticoid receptor antagonist, finerenone, have not been examined in patients
Jawad H. Butt+18 more
wiley +1 more source
Rehabilitation Protocols for Surgically Treated Acetabular Fractures in Older Adults: Current Practices and Outcomes. [PDF]
Ivanova S+5 more
europepmc +1 more source
Applying a simplified left atrial/natriuretic peptide (LA/NP) approach by combining enlarged LA volume indexed for height2 or elevated (N‐terminal pro) B‐type natriuretic peptide [(NT‐pro)BNP], using different cut‐off values for sinus rhythm (SR) and atrial fibrillation (AF) history.
Jerremy Weerts+13 more
wiley +1 more source